Pharmsville

Seoul, South Korea Founded: 2000 • Age: 26 yrs Listed
Nutraceutical products are manufactured by Pharmsville in Seoul.

About Pharmsville

Pharmsville is a publicly listed company based in Seoul (South Korea) founded in 2000. Nutraceutical products are manufactured by Pharmsville in Seoul. The company has 36 employees. Its chief executive, as recorded, is Byung Wook Lee. Its focus areas include Traditional Nutraceuticals and Diversified.

Company details

Pharmsville was established in 2000 and is located in Seoul, South Korea. Operations are centered on the nutraceutical sector, where a range of health-focused products are produced. The company is led by CEO and President Byung Wook Lee. Manufacturing activities are conducted to meet industry standards, with distribution handled primarily in the domestic market. Details on specific product lines or expansions are not publicly detailed.

  • Headquarters Seoul, South Korea
  • Employees 36
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website pharmsville.net
  • Legal Name Pharmsville Co., Ltd.
Key Metrics
  • Annual Revenue
    $8.81 M (USD)
    -23.9
    as on Dec 31, 2025
  • Net Profit
    $2 M (USD)
    82.47
    as on Dec 31, 2025
  • EBITDA
    -$84.78 K (USD)
    -138.56
    as on Dec 31, 2025
  • Employee Count
    36

People of Pharmsville

1 people are tracked at Pharmsville (1 in leadership); the tracked headcount is 36.

NameRoleGroup
Byung Wook Lee
CEO & PresidentLeadership
Premium access

Complete people profiles for Pharmsville

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Pharmsville

Pharmsville is a publicly listed company on the KRX with ticker symbol 318010 in South Korea, operating in the Retail trade sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date22 Oct 2019
  • Listed onKRX: 318010
  • Listed entityPharmsville Co., Ltd.
  • Exchange sectorRetail trade
  • ISINKR7318010006
  • Share price3,505.00 KRW (+0.86% on the day) · 2026-10-14
  • Market capitalisation26,855,209,851.00 KRW
  • Price to earnings9.1
  • EPS (diluted, trailing year)386.80 KRW
  • Dividend yield5.68%
  • Volume (last session)121

Financials of Pharmsville

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
202512.73B KRW2.89B KRW-122.4M KRW
202416.72B KRW1.58B KRW317.5M KRW
202321.39B KRW3.31B KRW2.23B KRW
202226.11B KRW4.06B KRW4.65B KRW
202139.03B KRW5.00B KRW6.28B KRW
Premium access

Detailed financial statements for Pharmsville

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Pharmsville

Websites that share an audience with Pharmsville (pharmsville.net).

Similar websites

Websites whose visitors overlap most with Pharmsville. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
i-appletree.com
100%
#2,737,683View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Pharmsville

Pharmsville was founded in 2000.

Pharmsville is headquartered in Seoul, South Korea.

Byung Wook Lee is the CEO of Pharmsville, as recorded in our data.

Pharmsville has 36 employees.

Annual revenue of Pharmsville is $8.81M as on Dec 31, 2025.

Pharmsville was established in 2000 and is located in Seoul, South Korea. Operations are centered on the nutraceutical sector, where a range of health-focused products are produced. The company is led by CEO and President Byung Wook Lee. Manufacturing activities are conducted to meet industry standards, with distribution handled primarily in the domestic market. Details on specific product lines or expansions are not publicly detailed.

Yes, Pharmsville is publicly traded on KRX under the ticker symbol 318010.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available